The company will develop the first orthopedic devices designed to reduce biofilm formation after implantation. The Semprus technology system creates a highly non-fouling performance that reduces the attachment of protein, cells, bacteria and other biological matter on medical device surfaces.
Related Articles on Orthopedic Devices:
Zimmer Signs Distribution Agreement for Benvenue Medical’s Vertebral Compression Fracture Treatment System
Stryker’s Net Earnings Decline, Acquisitions Save Sales Growth
K2M Launches Two Lateral Spine Surgery Systems Globally
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
